“Pharmstandard” will invest one billion rubles in modernization of the plant

“Pharmstandard-Leksredstva” plans to invest about 1 billion rubles in the modernization of the pharmaceutical factory in Kursk and to expand the product line. As writes “Kommersant” analysts expect growth of production at the plant from 600 to 700 million packages of medications a year.

“This will allow the company to create more jobs, increase productivity, and expand the range of products,” — said in the administration. Nomenclature of new drugs and the expected change of output (now the plant produces 600 million packages of medications a year) were not disclosed.

“Pharmstandard” has planned the modernization of the Kursk production on the background of rapid growth of the Russian pharmaceutical market, analysts said. According to the profile of consulting company DSM Group, in the first quarter of 2020, there was one of the most significant increases in sales over the last few years.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]